Biologically active supplements as an alternative in treatment of degenerative joint disease.
TN Potkin, Clinical Polyclinic ¹ 5, Kemerovo
According to WHO (2000), the overall prevalence of musculoskeletal (ODA) over 10 years (1988-1997.) Increased from 7.5 million to 11.2 million, an increase of more than 49%. Particularly drew attention to the fact that 46% of persons receiving disability with the defeat of Oda people of young age: Women younger than 44 years and men younger than 49 years. No less distressing, that the number of re-osvidetelstvuemyh disabled in 2,2-2,5 times higher than the number receiving disability for the first time (VA Nasonova, O.M, Folomeeva, 2000). Among patients in our clinic, contact us with pain from the DDA, 2 / 3 suffered from degenerative diseases, including osteoarthritis 12.8%, osteochondrosis - 33,8%, the most frequently affected joints are functionally important: 53% of the knee, spine - 22%, hip - 16%.
Osteoarthritis (OA), osteochondrosis - the most common diseases of ODA, which have important social value. The majority of patients refers to the doctor for help with pain in the knee or hip joints and as a consequence, restrictions on movements, which drastically reduces the quality of life. In 73% of cases, pain in the joints of the lower extremities occur against a background of degenerative disc disease of the lumbar and lumbosacral spine.
According to the Institute of Rheumatology RAMS, Moscow, in OA cartilage degeneration, a major sign of the disease, naturally associated with the occurrence of secondary inflammation of the synovial membrane. Pain - The main clinical manifestations of OA - is associated with the development of secondary synovitis. which in turn strengthens the processes of degradation of cartilage.
Experience has convinced us that in orthopedics with joint problems a plan of treatment policy should build on the general functional status of the patient, his age, state of ODA, rather than single joint.
The most frequently used in the treatment of osteoarthritis and degenerative disc disease medications include nonsteroidal anti-inflammatory drugs (NSAIDs). The global pharmaceutical industry offers a wide range of NSAIDs with different chemical structure. It is still an open question about the advantages and disadvantages of a group of NSAIDs, but you can not forget about adverse reactions and toxicity of these drugs.
According to the Clinic of Rheumatology rheumatological Institute in Warsaw, Prof. Filippovich-Sosnovska, the most common adverse effects of NSAID therapy should include violations of the digestive tract (enteropathy, ulceration and erosion of the stomach and intestines), the weakening of renal function, development of interstitial nephritis, renal necrosis papillae, acute renal failure with hypokalemia, skin changes.
The question of tolerance and possible complications of NSAIDs is particularly important when you consider that degenerative joint disease occur, usually in old age, when the pharmacokinetics of various drugs can vary due to changes in liver and kidney function.
We should not forget about the simple preventive measures available, the implementation of which could prevent further progression of degenerative joint disease - a daily exercise, proper nutrition.
Outstanding domestic scientist Academician AA Pokrovsky said: "Food should be regarded not only as a source of energy and plastic materials, but also as a highly sophisticated pharmacological complex.
The human body is a self-healing system, provided that the person lives in harmony with nature and with themselves. The last few years, according to published data, the treatment of degenerative diseases of ODA funds being used on the basis of substances similar in structure to the cartilage, bone, tendons, spinal discs, the vascular wall - glycosaminoglycans hondroetinsulfata.
In a comprehensive treatment of the DDA we have included the biologically active additives (BAA) of ARTLIFE - Joint Flex and BURDOK the purpose of research was to study their efficacy and tolerability.
The observation involved two groups of patients in 45 people aged 45 and older, suffering from gonarthrosis 2-3 stages (diagnosis confirmed radiologically) in 24 people comorbidity was osteochondrosis of the lumbar spine.
The first group received Joint Flex, in addition, receive an additional 5 persons BURDOK S.
The second group received the NSAID. Joint Flex appointed within a month to 2 tablets 2 times a day with follow-up within 6 months.
Results: Patients of the first group decreased pain after exercise, "night" pain, restore function in the joints. Adverse reactions were observed, was well tolerated dietary supplement.
In the control group because of adverse reactions to NSAIDs (such as nausea, epigastric pain) stopped treatment for 8 people, in what was a topical treatment,
Thus, BAA Joint Flex and BURDOK C is an effective tool in the treatment of osteoarthritis and degenerative disc disease, as it reduces pain, and for more prolonged use relieves pain and improves functional status of the joints, taking NSAIDs can reduce or even abandon their use.
Therapeutic effect persists for a long time (according to our observations). Evaluation of patients with the main group of his state as a whole (professional activity, private life, sports load) showed significant improvement in their quality of life.
Thus, dietary supplements company ARTLIFE are effective and safe means which can be used as a combined treatment, and independently of diseases of the locomotor system.
